Furthermore, the combination of CD20 and PAX5 expressions is useful in classifying DLBCL and PBL, with negative or weakly positive CD20 and PAX5 being characteristic phenotypes of PBL [26]. The gene discussed is PAX5; the disease is diffuse large B-cell lymphoma.